What is LLY's current EV/EBITDA?

Eli Lilly and Company's current EV/EBITDA is 30.6, which is above average relative to its 10-year historical range.

What is the 10-year average EV/EBITDA for LLY?

The approximate 10-year median EV/EBITDA for LLY is 26.9. The current reading of 30.6 is above average.

Eli Lilly and CompanyLLY

$1,098.57-13.43 (-1.21%)

NYSEHealthcare24:00 UTC

Earnings & Price

Price EPS (TTM)P/E ratio PEG

Book & Enterprise

P/B EV/EBITDA

Dividend

Dividend Yield Payout Ratio Div / Share

Cash & Leverage

FCF Yield Net Debt / EBITDA

An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.

Formula(Market Cap + Net Debt) / EBITDA

Full guide

EV/EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap

No data available

How to read this chart

Unlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.

Key caveats

EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.

Is LLY EV/EBITDA High or Low Right Now?

Eli Lilly and Company's EV/EBITDA is currently 30.6, which is above average relative to its 10-year historical range. The 10-year median EV/EBITDA for LLY is approximately 26.9. See all LLY valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.